Venky's (India)
- Market cap
- ₹ 2,246 Cr.
- P/E
- 12.8x
- P/B
- 1.44x
- 52-week range
- 1,165 – 1,814.9
- ROE
- 9%
- ROCE
- 12%
- Dividend yield
- 0.6%
- Debt / equity
- 0.1
- Sector
- Food Products
- Industry
- Meat Products including Poultry
- Listed on
- NSE, BSE
About
Venky's (India) Limited is an India-based company. The Company is engaged in the production of specific pathogen free (SPF) eggs, Processed Chicken, broiler and layer breeding, animal health products, poultry feed, soya bean extract and others in the poultry sector. The Company's segments include Poultry and Poultry Products, Animal Health Products, and Oilseed. The Poultry and Poultry Products segment produces and sells chicks, grownup commercial broiler, processed chicken, SPF eggs, poultry feed and other miscellaneous poultry products. The Animal Health Products segment produces and sells medicines and other health products for birds. The Oilseed Segment produces and sells edible refined soya oil and soya de-oiled cake. Its animal health care products include Nutritional Supplements, Toxin Binders, Early Chick Nutrition, Liver Tonics, Acidifiers, Health Promoters, Iron Tonic, Antibiotics, Anticoccidial, Anti-Mycoplasma, Dewormers, Anti-Gout, Electrolytes, and Certification.
Quick check
The five things to look at first. Open one for more.
Compared with its industry
Meat Products including Poultry: 6 companies →Venky's (India) against the typical company in its industry. The rank is out of the companies that report each figure; green means the better quarter of the pack, red the worse quarter.
- Valuation (P/E)12.8 against a typical 9: pricier than most peers (1st = cheapest).5th of 6
- Sales growth+29.1% against a typical +29.1% from a year earlier.3rd of 5
- Profit growth+212.5% against a typical +212.5% from a year earlier.3rd of 5
- Share price, 3 months+4.4% against a typical +6.7%.4th of 6
- Size₹ 2,246.2 Cr. market value against a typical ₹ 266.9 Cr. (1st = largest).1st of 5
Credit ratings
Every rating action on file, newest first, including reaffirmations. Open a row for the agency's reasoning. All credit rating updates
Adequate safety
Rated A+ by CARE- No warnings from the agency.
| Agency | Current rating | Outlook | As of |
|---|---|---|---|
| CARE | CARE A+ / CARE A1+ | Stable | 13 Jan 2026 |
| Rating | Details | |||||
|---|---|---|---|---|---|---|
| 13 Jan 2026 | Reaffirmed | CARE A+ / CARE A1+ | — | CARE | ₹ 311.5 Cr. |
Board meetings
Results dates and other board meetings. Full calendar
| Details | ||
|---|---|---|
| 13 Nov 2026Upcoming | Financial Results | To consider and approve the financial results for the period ended September 30, 2026 |
| 11 Aug 2026 | Financial Results | To consider and approve the financial results for the period ended Jun 30, 2026 |
| 14 May 2026 | Financial Results/Dividend | To consider and approve the financial results for the period ended March 31, 2026 and recommendation of dividend. |
| 9 Feb 2026 | Financial Results | To consider and approve the financial results for the period ended December 31, 2025 |
| 7 Nov 2025 | Financial Results | To consider and approve the financial results for the period ended September 30, 2025 |
| 8 Aug 2025 | Financial Results | To consider and approve the financial results for the period ended Jun 30, 2025 |
| 12 May 2025 | Financial Results/Dividend | To consider and approve the financial results for the period ended March 31, 2025 and dividend |
Financials
Standalone figures in ₹ crore.
| ₹ Cr. | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 913 | 953 | 896 | 808 | 774 | 882 | 843 | 866 | 801 | 960 | 1,100 | 1,118 |
| Expenses | 863 | 960 | 846 | 705 | 760 | 853 | 818 | 842 | 832 | 890 | 971 | 1,049 |
| Operating Profit | 50 | −7 | 50 | 103 | 14 | 29 | 25 | 24 | −31 | 70 | 130 | 69 |
| OPM % | 5% | −0.8% | 6% | 13% | 1.8% | 3.3% | 3% | 2.7% | −3.9% | 7% | 12% | 6% |
| Other Income | 9 | 10 | 11 | 10 | 10 | 12 | 12 | 12 | 10 | 10 | 16 | 13 |
| Interest | 5 | 5 | 4 | 4 | 4 | 4 | 4 | 4 | 5 | 4 | 3 | 4 |
| Depreciation | 9 | 9 | 9 | 9 | 9 | 9 | 10 | 9 | 9 | 9 | 9 | 9 |
| Profit before tax | 46 | −10 | 47 | 101 | 11 | 28 | 23 | 22 | −35 | 66 | 133 | 69 |
| Tax % | 26% | −24% | 29% | 25% | 29% | 27% | 42% | 27% | −24% | 27% | 24% | 28% |
| Net Profit | 34 | −8 | 34 | 75 | 8 | 20 | 13 | 16 | −27 | 49 | 101 | 50 |
| EPS in Rs | 24.2 | −5.64 | 23.79 | 53.37 | 5.51 | 14.47 | 9.44 | 11.24 | −18.83 | 34.48 | 71.96 | 35.49 |
Growth and returns
Compounded yearly rates over each period.
- 10 Years
- 6%
- 5 Years
- 4%
- 3 Years
- −4%
- TTM
- 18%
- 10 Years
- 14%
- 5 Years
- −12%
- 3 Years
- 25%
- TTM
- 203%
- 10 Years
- 13%
- 5 Years
- −9%
- 3 Years
- −6%
- TTM
- —
- 10 Years
- 13%
- 5 Years
- 8%
- 3 Years
- 8%
- TTM
- —
P/E and EPS over time
Daily P/E and trailing 12-month EPS. EPS updates with each result.
Peers
Listed companies in the same business.
| Venky's (India) | ₹ 1,577.50 | ₹ 2,246 Cr. | 12.8x | 1.4x | 9% | — |
| Heritage Foods | ₹ 349.30 | ₹ 3,241 Cr. | 21.5x | 2.8x | 14.6% | 3.3% |
| Apex Frozen Foods | ₹ 302.70 | ₹ 940 Cr. | 32.4x | 2.4x | 7.6% | 4.2% |
| Waterbase | ₹ 40.90 | ₹ 170 Cr. | — | 1.3x | −9.9% | −4.2% |
| Zeal Aqua | ₹ 9.72 | ₹ 123 Cr. | 10.2x | 1.4x | 14.7% | 2.1% |
| Modern Dairies | ₹ 40.80 | ₹ 116 Cr. | 17.6x | 1.6x | 10.2% | 1.4% |
Management
- Jiwan Kumar Handa
- Chief Financial Officer
- Rohan Ajay Bhagwat
- Compliance Officer, Company Secretary
- B. Balaji Rao
- Managing Director, Executive Director
Prices are delayed and for information only. Nothing on this page is investment advice.